The Effect of Acotiamide on Nausea as a Symptom of Chronic Nausea and Vomiting Syndrome after Coronavirus Disease 2019.

Abstract

Chronic nausea and vomiting syndrome (CNVS), one of a functional gastroduodenal disorder, was identified in an 8-year-old girl and a 13-year-old boy who had complained of nausea for more than 4 months following coronavirus disease 2019 (COVID-19) due to normality of their head computed tomography and upper gastrointestinal tract images. The patients' symptoms responded quickly to acotiamide, a medication that is effective for treating functional dyspepsia (FD). Despite being a distinct illness from FD, CNVS is also a functional gastrointestinal disorder, and acotiamide may be just as effective for CNVS following COVID-19 as for FD.

• Authors: Toshihiko Kakiuchi, Masato Yoshiura
• Journal: Internal medicine (Tokyo, Japan) (Intern Med) Vol. 62 Issue 5 Pg. 739-743 (Mar 01 2023) ISSN: 1349-7235 [Electronic] Japan
• PMID: 36543215 (Publication Type: Case Reports, Journal Article)

Chemical References

• Z 338

Topics

• Male
• Female
• Humans
• Child
• Adolescent
• Treatment Outcome
• COVID-19
• Dyspepsia
• Nausea
• Vomiting